Investors in Puma Biotechnology, Inc. PBYI need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $5 Put had some of the highest implied...
Investors in Puma Biotechnology, Inc. PBYI need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $5 Put had some of the highest implied...
Puma Biotechnology PBYI reported fourth-quarter 2024 adjusted earnings of 43 cents per share, which beat the Zacks Consensus Estimate of 14 cents. In the year-ago quarter, the company reported adjusted...
Vir Biotechnology, Inc. VIR announced encouraging initial data from a phase I study that evaluated its investigational pipeline candidates, VIR-5818 and VIR-5500, for the treatment of various solid tumors.While...
Shares of CorMedix CRMD rose nearly 30% on Tuesday after management announced fourth-quarter and full-year 2024 preliminary sales figures.CorMedix’s Preliminary Sales Figures Beat EstimatesCorMedix reported...
For Geron Corporation GERN, 2024 was a transformational year as it saw the FDA approval and commercial launch of Rytelo (imetelstat)Â for the treatment of low- to intermediate-1 risk myelodysplastic syndromes...
Atara Biotherapeutics ATRA is a nimble allogeneic T cell immunotherapy company with several near-term catalysts. This Zacks Rank #2 (Buy) company boasts a pipeline of differentiated therapies across a...
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 6:NRx Pharmaceuticals, Inc. NRXP: This bio-pharmaceutical company has a Zacks Rank #1 and...
Here are three stocks with buy rank and strong value characteristics for investors to consider today, January 6:Ashford Hospitality Trust, Inc. AHT: This real estate investment trust carries a Zacks Rank...